Safety Study of Larazotide Acetate to Treat Celiac Disease.

NCT00386165 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: larazotide acetate

Sponsor

9 Meters Biopharma, Inc.